SGN-40: Phase Ib started

The partners began an open-label, dose-escalation, U.S. Phase Ib trial of SGN-40 in combination with Gemzar gemcitabine and Rituxan rituximab in 30 patients. Gemzar is marketed by Eli Lilly and Co....